{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T19:43:00Z","timestamp":1777318980367,"version":"3.51.4"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002301","name":"Estonian Research Council","doi-asserted-by":"publisher","award":["PRG1844"],"award-info":[{"award-number":["PRG1844"]}],"id":[{"id":"10.13039\/501100002301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["RITA 1\/02-120"],"award-info":[{"award-number":["RITA 1\/02-120"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["806968"],"award-info":[{"award-number":["806968"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["101034347"],"award-info":[{"award-number":["101034347"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Union's Horizon 2020"},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To introduce 2 R-packages that facilitate conducting health economics research on OMOP-based data networks, aiming to standardize and improve the reproducibility, transparency, and transferability of health economic models.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Materials and Methods<\/jats:title>\n                  <jats:p>We developed the software tools and demonstrated their utility by replicating a UK-based heart failure data analysis across 5 different international databases from Estonia, Spain, Serbia, and the United States.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We examined treatment trajectories of 47 163 patients. The overall incremental cost-effectiveness ratio (ICER) for telemonitoring relative to standard of care was 57 472 \u20ac\/QALY. Country-specific ICERs were 60 312 \u20ac\/QALY in Estonia, 58 096 \u20ac\/QALY in Spain, 40 372 \u20ac\/QALY in Serbia, and 90 893 \u20ac\/QALY in the US, which surpassed the established willingness-to-pay thresholds.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>Currently, the cost-effectiveness analysis lacks standard tools, is performed in ad-hoc manner, and relies heavily on published information that might not be specific for local circumstances. Published results often exhibit a narrow focus, central to a single site, and provide only partial decision criteria, limiting their generalizability and comprehensive utility.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>We created 2 R-packages to pioneer cost-effectiveness analysis in OMOP CDM data networks. The first manages state definitions and database interaction, while the second focuses on Markov model learning and profile synthesis. We demonstrated their utility in a multisite heart failure study, comparing telemonitoring and standard care, finding telemonitoring not cost-effective.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jamia\/ocae044","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T03:59:05Z","timestamp":1710302345000},"page":"1093-1101","source":"Crossref","is-referenced-by-count":6,"title":["Markov modeling for cost-effectiveness using federated health data network"],"prefix":"10.1093","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0935-3307","authenticated-orcid":false,"given":"Markus","family":"Haug","sequence":"first","affiliation":[{"name":"Institute of Computer Science, University of Tartu , Tartu 51009, Estonia"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3650-8194","authenticated-orcid":false,"given":"Marek","family":"Oja","sequence":"additional","affiliation":[{"name":"Institute of Computer Science, University of Tartu , Tartu 51009, Estonia"}]},{"given":"Maarja","family":"Pajusalu","sequence":"additional","affiliation":[{"name":"Institute of Computer Science, University of Tartu , Tartu 51009, Estonia"}]},{"given":"Kerli","family":"Mooses","sequence":"additional","affiliation":[{"name":"Institute of Computer Science, University of Tartu , Tartu 51009, Estonia"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6835-9632","authenticated-orcid":false,"given":"Sulev","family":"Reisberg","sequence":"additional","affiliation":[{"name":"Institute of Computer Science, University of Tartu , Tartu 51009, Estonia"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5604-4107","authenticated-orcid":false,"given":"Jaak","family":"Vilo","sequence":"additional","affiliation":[{"name":"Institute of Computer Science, University of Tartu , Tartu 51009, Estonia"}]},{"given":"Antonio Fern\u00e1ndez","family":"Gim\u00e9nez","sequence":"additional","affiliation":[{"name":"Biomedical Research Institute, IIS INCLIVA , Valencia 46010, Spain"}]},{"given":"Thomas","family":"Falconer","sequence":"additional","affiliation":[{"name":"Columbia University Irving Medical Center , New York, NY 10032, United States"}]},{"given":"Ana","family":"Danilovi\u0107","sequence":"additional","affiliation":[{"name":"KBC Zvezdara , Belgrade 11000, Serbia"}]},{"given":"Filip","family":"Maljkovic","sequence":"additional","affiliation":[{"name":"Department of Health Information Systems, Heliant , Belgrade 11000, Serbia"}]},{"given":"Dalia","family":"Dawoud","sequence":"additional","affiliation":[{"name":"National Institute for Health and Care Excellence , London WC1V 6NA, United Kingdom"}]},{"given":"Raivo","family":"Kolde","sequence":"additional","affiliation":[{"name":"Institute of Computer Science, University of Tartu , Tartu 51009, Estonia"}]}],"member":"286","published-online":{"date-parts":[[2024,3,12]]},"reference":[{"key":"2024041923350109300_ocae044-B1","volume-title":"Health Economics: An Introduction to Economic Evaluation","author":"Kobelt","year":"2013","edition":"3rd ed"},{"key":"2024041923350109300_ocae044-B2","author":"Romeu","year":"2020"},{"issue":"25","key":"2024041923350109300_ocae044-B3","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1002\/sim.8681","article-title":"A hidden Markov model for population-level cervical cancer screening data","volume":"39","author":"Soper","year":"2020","journal-title":"Stat Med"},{"issue":"1","key":"2024041923350109300_ocae044-B4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1186\/s12859-021-04364-5","article-title":"Concentration optimization of combinatorial drugs using Markov chain-based models","volume":"22","author":"Ma","year":"2021","journal-title":"BMC Bioinformatics"},{"issue":"6","key":"2024041923350109300_ocae044-B5","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jval.2020.02.012","article-title":"Developing Markov models from real-world data: a case study of heart failure modeling using administrative data","volume":"23","author":"Thokala","year":"2020","journal-title":"Value Health"},{"issue":"10","key":"2024041923350109300_ocae044-B6","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/pds.4975","article-title":"Real-world evidence to support regulatory decision-making for medicines: considerations for external control arms","volume":"29","author":"Burcu","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"2024041923350109300_ocae044-B7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40273-020-00981-9","article-title":"Common problems, common data model solutions: evidence generation for health technology assessment","volume":"39","author":"Kent","year":"2021","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"2024041923350109300_ocae044-B8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/cpt.1426","article-title":"Real-world data for regulatory decision making: challenges and possible solutions for Europe","volume":"106","author":"Cave","year":"2019","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"2024041923350109300_ocae044-B9","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1038\/s41467-022-32310-3","article-title":"Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions","volume":"13","author":"Wang","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"2024041923350109300_ocae044-B10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1161\/CIRCOUTCOMES.108.812321","article-title":"The limits of cost-effectiveness analysis","volume":"2","author":"Weintraub","year":"2009","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"1","key":"2024041923350109300_ocae044-B11","first-page":"3","article-title":"Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations","volume":"25","author":"Husereau","year":"2022","journal-title":"Int J Technol Assess Health Care"},{"key":"2024041923350109300_ocae044-B12","doi-asserted-by":"crossref","first-page":"1073678","DOI":"10.3389\/fmed.2022.1073678","article-title":"Transferability of real-world data across borders for regulatory and health technology assessment decision-making","volume":"9","author":"Jaksa","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"2024041923350109300_ocae044-B13","first-page":"574","article-title":"Observational health data sciences and informatics (OHDSI): opportunities for observational researchers","volume":"216","author":"Hripcsak","year":"2015","journal-title":"Stud Health Technol Inform"},{"key":"2024041923350109300_ocae044-B14","first-page":"95","article-title":"The usage of OHDSI OMOP\u2014a scoping review","volume":"283","author":"Reinecke","year":"2021","journal-title":"Stud Health Technol Inform"},{"key":"2024041923350109300_ocae044-B15","author":"OHDSI","year":"2021"},{"key":"2024041923350109300_ocae044-B16","author":"European Medicines Agency","year":"2020"},{"key":"2024041923350109300_ocae044-B17","author":"Incerti","year":"2021"},{"issue":"8","key":"2024041923350109300_ocae044-B18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v038.i08","article-title":"Multi-state models for panel data: the msm Package for R","volume":"38","author":"Jackson","year":"2011","journal-title":"J Stat Softw"},{"key":"2024041923350109300_ocae044-B19","author":"Haug","year":"2023"},{"key":"2024041923350109300_ocae044-B20","author":"Haug","year":"2023"},{"key":"2024041923350109300_ocae044-B21","author":"Haug","year":"2023"},{"key":"2024041923350109300_ocae044-B22","author":"Rosa","year":"2022"},{"key":"2024041923350109300_ocae044-B23","doi-asserted-by":"crossref","first-page":"107081","DOI":"10.1016\/j.cmpb.2022.107081","article-title":"TreatmentPatterns: an R package to facilitate the standardized development and analysis of treatment patterns across disease domains","volume":"225","author":"Markus","year":"2022","journal-title":"Comput Methods Programs Biomed"},{"key":"2024041923350109300_ocae044-B24","author":"Pajusalu","year":"2022"},{"key":"2024041923350109300_ocae044-B25","first-page":"55","author":"Norris","year":"1998"},{"issue":"1","key":"2024041923350109300_ocae044-B26","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/biomet\/68.1.316","article-title":"The asymptotic properties of nonparametric tests for comparing survival distributions","volume":"68","author":"Schoenfeld","year":"1981","journal-title":"Biometrika"},{"issue":"32","key":"2024041923350109300_ocae044-B27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17320","article-title":"Home telemonitoring or structured telephone support programmes aper recent discharge in patients with heart failure: systematic review and economic evaluation","volume":"17","author":"Pandor","year":"2013","journal-title":"Health Technol Assess"},{"key":"2024041923350109300_ocae044-B28","author":"OECD Data Warehouse","year":"2023"},{"key":"2024041923350109300_ocae044-B29","author":"The Government of the Republic of Estonia. List of healthcare services of the Estonian Health Insurance Fund","year":"2021"},{"key":"2024041923350109300_ocae044-B30","author":"Estonian Health Insurance Fund. Cost-effectiveness and medical insurance budget impact assessment \u201cTelemetric ECG monitoring\u201d","year":"2019"},{"key":"2024041923350109300_ocae044-B31","first-page":"237","author":"Edejer","year":"2003"},{"key":"2024041923350109300_ocae044-B32","author":"Pokrovski","year":"2019"},{"issue":"4","key":"2024041923350109300_ocae044-B33","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/hec.3633","article-title":"Estimating a cost-effectiveness threshold for the Spanish NHS","volume":"27","author":"Vallejo-Torres","year":"2018","journal-title":"Health Econ"},{"issue":"7","key":"2024041923350109300_ocae044-B34","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/clc.22696","article-title":"Cost-effectiveness of remote cardiac monitoring with the CardioMEMS Heart Failure System","volume":"40","author":"Schmier","year":"2017","journal-title":"Clin Cardiol"},{"issue":"2","key":"2024041923350109300_ocae044-B35","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/10408363.2018.1561640","article-title":"Automation and artificial intelligence in the clinical laboratory","volume":"56","author":"Naugler","year":"2019","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"12","key":"2024041923350109300_ocae044-B36","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/j.1469-0691.2010.03331.x","article-title":"Understanding cost-effectiveness","volume":"16","author":"Zilberberg","year":"2010","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"2024041923350109300_ocae044-B37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jceh.2019.11.001","article-title":"Cost-effectiveness analysis and decision modelling: a tutorial for clinicians","volume":"10","author":"Nidhi","year":"2020","journal-title":"J Clin Exp Hepatol"},{"issue":"4","key":"2024041923350109300_ocae044-B38","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s10557-021-07310-y","article-title":"Cost-effectiveness of lipid-lowering therapies for cardiovascular prevention in Germany","volume":"37","author":"Michaeli","year":"2023","journal-title":"Cardiovasc Drugs Ther"},{"key":"2024041923350109300_ocae044-B39","doi-asserted-by":"crossref","first-page":"675200","DOI":"10.3389\/fcvm.2021.675200","article-title":"Cost-effectiveness analysis of direct oral anticoagulants vs. Vitamin k antagonists in the elderly with atrial fibrillation: insights from the evidence in a real-world setting","volume":"8","author":"Wu","year":"2021","journal-title":"Front Cardiovasc Med"}],"container-title":["Journal of the American Medical Informatics Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jamia\/article-pdf\/31\/5\/1093\/57286256\/ocae044.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jamia\/article-pdf\/31\/5\/1093\/57286256\/ocae044.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T23:35:35Z","timestamp":1713569735000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jamia\/article\/31\/5\/1093\/7627292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,12]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,3,12]]},"published-print":{"date-parts":[[2024,4,19]]}},"URL":"https:\/\/doi.org\/10.1093\/jamia\/ocae044","relation":{},"ISSN":["1067-5027","1527-974X"],"issn-type":[{"value":"1067-5027","type":"print"},{"value":"1527-974X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,5,1]]},"published":{"date-parts":[[2024,3,12]]}}}